DE SB278 | 2011-2012 | 146th General Assembly

Status

Spectrum: Slight Partisan Bill (Democrat 4-2)
Status: Enrolled on June 27 2012 - 75% progression, died in committee
Action: 2012-06-28 - Introduced and Assigned to Health & Human Development Committee in House
Pending: House Health & Human Development Committee
Text: Latest bill text (Draft #1) [HTML]

Summary

Section 1 creates the Controlled Substance Advisory Committee, a designee/recommending body that previously existed only in regulation; makes numerous grammatical corrections; makes uniform the language pertaining to the Secretary’s duty to the public interest; codifies requirements applicants must meet before they are issued a controlled substance registration; adds discipline of one’s professional license as a basis to have a controlled substance registration denied or disciplined; limits the Secretary’s power to issue a rule to show cause order to those instances in which a registrant no longer meets the requirements for registration or has failed to complete mandatory continued education; increases the Secretary’s power to fine from $500 to $1,000 per offense; clarifies that all hearings contemplated by this Subchapter are governed by the APA; and revamps the Secretary’s power to temporarily suspend a controlled substance registration to create a process akin to that used by the Board of Medical Licensure & Discipline. Section 2 corrects 4798 (b)(9)(c) by deleting the word “prescribes” and replacing it with “dispenses”. Section 2 of this bill also creates a new requirement that dispensers check the patient utilization report for the past 12 months of any patient that the dispenser has a reasonable belief may be seeking controlled substances for any non-medical reason. This provision was inadvertently omitted from the initial bill creating the Prescription Monitoring Program.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

An Act To Amend Title 16 Of The Delaware Code Relating To The Regulation Of The Manufacture, Distribution And Dispensing Of Controlled Substances, And The Delaware Prescription Monitoring Program.

Sponsors


Roll Calls

2012-06-27 - Senate - Senate Third Reading (Y: 21 N: 0 NV: 0 Abs: 0) [PASS]

History

DateChamberAction
2012-06-28 Introduced and Assigned to Health & Human Development Committee in House
2012-06-27 Passed by Senate. Votes: Passed 21 YES 0 NO 0 NOT VOTING 0 ABSENT 0 VACANT
2012-06-27 Amendment SA 1 - Passed by Senate. Votes: Passed 21 YES 0 NO 0 NOT VOTING 0 ABSENT 0 VACANT
2012-06-27 Amendment SA 1 - Introduced in Senate
2012-06-27 Necessary rules are suspended in Senate
2012-06-26 Laid On Table in Senate

Delaware State Sources


Bill Comments

feedback